Early Catheter Removal After Robot-assisted Radical Prostatectomy: Results from a Prospective Single-institutional Randomized Trial (Ripreca Study).


Journal

European urology focus
ISSN: 2405-4569
Titre abrégé: Eur Urol Focus
Pays: Netherlands
ID NLM: 101665661

Informations de publication

Date de publication:
15 03 2020
Historique:
received: 22 08 2018
revised: 08 10 2018
accepted: 23 10 2018
pubmed: 11 11 2018
medline: 21 5 2021
entrez: 11 11 2018
Statut: ppublish

Résumé

The adoption of robotic technology in the treatment of prostate cancer (PCa) could lead to improvement in outcomes. To evaluate feasibility, to compare functional outcomes, and to assess the economic benefits of removing catheter on the postoperative day (POD) 3 versus POD 5 after robot-assisted radical prostatectomy (RARP). From September 2016 to May 2017, patients selected to undergo RARP for clinically localized PCa at a high-volume center were prospectively randomized into group 1 (POD 3; n=72) versus group 2 (POD 5, n=74). All patients underwent RARP with anatomical posterior and anterior reconstruction. The primary endpoint was to compare acute urinary retention (AUR) and urinary leakage rate in the two groups. The secondary endpoints were early and mid-term postoperative functional outcomes assessed through questionnaires (ICIQ-MLUTS, IPSS), early continence rate, and postoperative pain/discomfort (visual analog scale score). The economic impact of early catheter removal was also assessed. AUR was reported in two (1.4%) cases, one for each study group (p=0.9). One case of vesicourethral leakage was reported (0.7%) in group 1. Urethral discomfort and pain at discharge was significantly higher in group 2 (p=0.03). In our clinical practice, POD 3 catheter removal approach would determine a saving of approximately €80 000 and 405 d of hospitalization yearly. The main limitation is the small sample size. Early catheter removal after RARP does not lead to an increase in perioperative complications. No negative effect on early and mid-term functional outcomes was observed. A significant impact on saving economic resources was reported. We demonstrated that early catheter removal has no negative effect on spontaneous voiding, complications, or urinary continence recovery after robot-assisted radical prostatectomy.

Sections du résumé

BACKGROUND
The adoption of robotic technology in the treatment of prostate cancer (PCa) could lead to improvement in outcomes.
OBJECTIVE
To evaluate feasibility, to compare functional outcomes, and to assess the economic benefits of removing catheter on the postoperative day (POD) 3 versus POD 5 after robot-assisted radical prostatectomy (RARP).
DESIGN, SETTING, AND PARTICIPANTS
From September 2016 to May 2017, patients selected to undergo RARP for clinically localized PCa at a high-volume center were prospectively randomized into group 1 (POD 3; n=72) versus group 2 (POD 5, n=74).
INTERVENTION
All patients underwent RARP with anatomical posterior and anterior reconstruction.
OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS
The primary endpoint was to compare acute urinary retention (AUR) and urinary leakage rate in the two groups. The secondary endpoints were early and mid-term postoperative functional outcomes assessed through questionnaires (ICIQ-MLUTS, IPSS), early continence rate, and postoperative pain/discomfort (visual analog scale score). The economic impact of early catheter removal was also assessed.
RESULTS AND LIMITATIONS
AUR was reported in two (1.4%) cases, one for each study group (p=0.9). One case of vesicourethral leakage was reported (0.7%) in group 1. Urethral discomfort and pain at discharge was significantly higher in group 2 (p=0.03). In our clinical practice, POD 3 catheter removal approach would determine a saving of approximately €80 000 and 405 d of hospitalization yearly. The main limitation is the small sample size.
CONCLUSIONS
Early catheter removal after RARP does not lead to an increase in perioperative complications. No negative effect on early and mid-term functional outcomes was observed. A significant impact on saving economic resources was reported.
PATIENT SUMMARY
We demonstrated that early catheter removal has no negative effect on spontaneous voiding, complications, or urinary continence recovery after robot-assisted radical prostatectomy.

Identifiants

pubmed: 30413390
pii: S2405-4569(18)30314-6
doi: 10.1016/j.euf.2018.10.013
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

259-266

Informations de copyright

Copyright © 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Auteurs

Giuliana Lista (G)

Urology, Humanitas Clinical and Research Hospital, Rozzano, Milan, Italy. Electronic address: giuliana.lista@aulss8.veneto.it.

Giovanni Lughezzani (G)

Urology, Humanitas Clinical and Research Hospital, Rozzano, Milan, Italy.

Nicolò Maria Buffi (NM)

Urology, Humanitas Clinical and Research Hospital, Rozzano, Milan, Italy; Humanitas University, Rozzano, Milan, Italy.

Alberto Saita (A)

Urology, Humanitas Clinical and Research Hospital, Rozzano, Milan, Italy.

Elena Vanni (E)

Business Operations Office, Humanitas Clinical and Research Center, Milan, Italy; Department of Biomedical Science, Humanitas University, Milan, Italy.

Rodolfo Hurle (R)

Urology, Humanitas Clinical and Research Hospital, Rozzano, Milan, Italy.

Pasquale Cardone (P)

Urology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, FG, Italy.

Roberto Peschechera (R)

Urology, Humanitas Clinical and Research Hospital, Rozzano, Milan, Italy.

Giovanni Forni (G)

Humanitas University, Rozzano, Milan, Italy.

Massimo Lazzeri (M)

Urology, Humanitas Clinical and Research Hospital, Rozzano, Milan, Italy.

Giorgio Guazzoni (G)

Urology, Humanitas Clinical and Research Hospital, Rozzano, Milan, Italy; Humanitas University, Rozzano, Milan, Italy.

Paolo Casale (P)

Urology, Humanitas Clinical and Research Hospital, Rozzano, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH